欧谱曼迪 is a national high‑tech enterprise focused on the development and production of high‑end medical devices. The group’s Guangdong entity has taken a leading position in the fluorescence laparoscope field. The company is also building out a soft‑endoscope business line and planning a disposable electronic endoscope product line and surgical treatment–related devices. Its Suzhou subsidiary has obtained five NMPA registration certificates, including an HD white‑light ureteroscope system. Recently the company completed a strategic financing of several tens of millions of RMB. The raise supports its product-line expansion and regulatory/commercial efforts. Guangdong Oupumandi Technology Co., Ltd. (欧谱曼迪), founded in 2013 and headquartered in Foshan, is a platform innovator in medical endoscopes. Its product line covers host systems and scopes for both rigid and flexible endoscopes, plus supporting instruments and contrast agents. The company has developed proprietary core technologies in minimally invasive imaging, intelligent imaging platforms, and scope design and manufacturing, and has launched multiple first‑in‑China products including NMPA‑approved HD and 4K fluorescence endoscope systems. Oupumandi has commercialized platform products such as the Stellar system that integrates fluorescence imaging, 3D and 4K, and is developing the 214KM dual‑fluorescence system. Its products are used in over 300 tertiary hospitals domestically, have entered several European markets, and have received recognition from the International Society for Fluorescence‑Guided Surgery (ISFGS). The company plans to use new capital to productize several major innovations, expand its global marketing and channel network, and strengthen its competitive position in the endoscopy field. Oupumandi has attracted strategic and institutional investors over the past year, including Alibaba, YaHui Investment, and the China Life large pension fund.

Total raised

$28M

Funding rounds

2

Latest round

Equity

Latest activity

Jul 2023